Clinical Trials Logo
  1. Home
  2. Atrophic Vaginitis
  3. NCT00167921
  4. Details
NCT00167921 Clinical Trial

Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis

Atrophic Vaginitis Clinical Trial

Official title:
A Multiple-Dose, Comparative Bioavailability Study of Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Postmenopausal Women With Atrophic Vaginitis.

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00167921
Other study ID # 0713S5-414
Secondary ID
Status Completed
Phase Phase 1
First received September 9, 2005
Last updated May 25, 2007
Start date October 2005

Study information
Verified date May 2007
Source Wyeth is now a wholly owned subsidiary of Pfizer
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The purpose of this study is to characterize the systemic exposure and bioavailability at steady state of Premarin® Vaginal Cream compared with Premarin® oral tablets in postmenopausal women with atrophic vaginitis.

Recruitment information / eligibility
Status Completed
Enrollment 24
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Female
Age group 45 Years to 80 Years
Eligibility Inclusion Criteria:

- Generally healthy postmenopausal women.

- Intact uterus.

- Clinical diagnosis of moderate to severe atrophic vaginitis.

Study Design

Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Open Label

Related Conditions & MeSH terms

Intervention

Drug:
• Premarin® Vaginal Cream

• Premarin® oral tablets

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Wyeth is now a wholly owned subsidiary of Pfizer

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary To characterize the systemic exposure and bioavailability at steady state of Premarin® Vaginal Cream compared with oral Premarin® tablets in postmenopausal women with atrophic vaginitis.
Secondary To estimate the systemic exposure in postmenopausal women taking a typical regimen.
See also
  Status Clinical Trial Phase
Completed NCT00984399 - Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen N/A
Completed NCT04079218 - Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial Phase 4
Recruiting NCT05953090 - VALOR: Vaginal Atrophy & Long-term Observation of Recovery N/A
Terminated NCT00816556 - A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis Phase 3
Completed NCT04327947 - Evaluation of Gynecological Acceptability of 3 Health Care Products N/A
Recruiting NCT05118685 - Estrogen and Platelet Rich Plasma in Treatment of Atrophic Vaginitis Phase 1
Completed NCT03294538 - Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis Phase 3
Completed NCT05058313 - Evaluation of the Safety and Performance of the MILTA GYNECO Vaginal Probe in Postmenopausal Women With Vaginal Atrophy N/A
Completed NCT02995694 - A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic Vaginitis Phase 3
Completed NCT02691936 - Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy N/A
Recruiting NCT06305494 - Genitourinary Syndrome of Menopause in Thai Gynecologic Cancer Survivors
Completed NCT02195986 - A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis Phase 3
Recruiting NCT03981458 - Hyaluronate for the Treatment and Prevention of Recurrent Urinary Tract Infection in Women Suffering Atrophic Vaginitis N/A
Completed NCT05396261 - a Flexible Wound Dressing for the Management of Genital Skin Conditions N/A
Completed NCT02869165 - Vaginal and Urinary Microbiome Trial Phase 4
Completed NCT02029053 - Preliminary Study of a Vaginal Lubrication Ring to Treat the Symptoms of Vaginal Dryness Phase 0
Not yet recruiting NCT06176820 - Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause Phase 2/Phase 3
Recruiting NCT02733731 - The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis Phase 1
Withdrawn NCT02460302 - Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy Phase 2
Completed NCT02313545 - Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of AV and DIV Phase 1/Phase 2